TAXUS? ELEMENT?
Report
- Report Number
- 2134265-2013-06326
- Event Type
- Death
- Date Received
- September 18, 2013
- Date of Event
- September 30, 2012
- Report Date
- August 20, 2013
- Product Code
- NIQ
- PMA / PMN Number
- P100023
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- PHYSICIAN
Narratives
DEVICE EVALUATED BY MANUFACTURER: THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE, A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).
SAME CASE AS MDR ID# 2134265-2013-06325; SAME CASE AS MDR ID# 2134265-2013-06328; SAME CASE AS MDR ID# 2134265-2013-06329; SAME CASE AS MDR ID# 2134265-2013-06373. (B)(4). IT WAS REPORTED THAT POST A PERCUTANEOUS CORONARY INTERVENTION PROCEDURE, THE PATIENT EXPERIENCED A MYOCARDIAL INFARCTION AND EXPIRED. IN (B)(6) 2011, THE PATIENT PRESENTED DUE TO STABLE ANGINA. THE PHYSICIAN TREATED THREE DIFFERENT LESIONS. LESION 1 WAS A LONG LESION LOCATED IN THE PROXIMAL LEFT ANTERIOR DESCENDING (LAD) ARTERY TO DISTAL LAD WITH 75% STENOSIS AND WAS 65 MM LONG WITH A REFERENCE VESSEL DIAMETER OF 2.75 MM. THE PHYSICIAN TREATED THE LESION WITH PRE-DILATATION AND IMPLANTATION OF OVERLAPPING 2.5 X 24 MM, 2.5 X 32 MM , AND 3.0 X 16 MM TAXUS ELEMENT STENTS. FOLLOWING POST-DILATATION, RESIDUAL STENOSIS WAS 0%. LESION 2 WAS LOCATED IN THE 1ST DIAGONAL WITH 75% STENOSIS AND WAS 12 MM LONG WITH A REFERENCE VESSEL DIAMETER OF 2.4 MM. THE PHYSICIAN TREATED THE LESION WITH DIRECT STENT PLACEMENT USING A 2.5 X 16 MM TAXUS ELEMENT STENT WITH 0% RESIDUAL STENOSIS. LESION 3 WAS LOCATED IN THE 2ND OBTUSE MARGINAL WITH 75% STENOSIS AND WAS 15 MM LONG WITH A REFERENCE VESSEL DIAMETER OF 2.8 MM. THE PHYSICIAN TREATED THE LESION WITH DIRECT STENT PLACEMENT OF A 3.0 X 20 MM TAXUS ELEMENT STENT WITH 0% RESIDUAL STENOSIS. POST INDEX PROCEDURE, THE PATIENT HAD ELEVATED TROPONIN VALUES (PEAK TROPONIN= 137 NG/L, UL= 14 NG/L). NO ISCHEMIC SYMPTOMS WERE OBSERVED AND NO ACTION WAS TAKEN TO TREAT THIS EVENT. THE PATIENT WAS DISCHARGED 2 DAYS LATER ON ASPIRIN AND CLOPIDOGREL. IN (B)(6) 2013, 438 DAYS POST INDEX PROCEDURE, THE PATIENT EXPERIENCED AN MYOCARDIAL INFARCTION AND SUBSEQUENTLY EXPIRED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 469528 | TAXUS? ELEMENT? | CORONARY DRUG-ELUTING STENT | NIQ | H7493902532250 | 13720332 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 55 YR | Death |